The use of ICS in COPD: Discussing new European Respiratory Society Guidelines

In this episode of the Medical Insider COPD podcast, join Dr Richard Russell and Professor James Chalmers as they discuss the implications of the recent European Respiratory Society Guidelines on COPD patient care.¹ Listen as the experts debate the use of inhaled corticosteroids and discuss who is most likely to benefit from their withdrawal. ¹ Dr Russell also shares highlights from a publication about patients’ healthcare system encounters before they receive a COPD diagnosis.² Finally, Dr Russell delves into a hot social media topic, looking at the implications that diet and nutrition can have for patients with COPD.

^1. Chalmers JD, et al. Eur Respir J 2020;55:2000351;
^2. Johnson KM, et al. Thorax 2020;75:108–115.

Disclosures
Professor James Chalmers

Professor James Chalmers has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Grifols, Insmed, Janssen, Novartis and Zambon
Research grant support from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Insmed and Novartis

Dr Richard Russell

Dr Richard Russell has received speaker fees from AstraZeneca, GlaxoSmithKline, Chiesi, Boehringer Ingelheim.
Project grant support from AstraZeneca

Funding statement
This podcast programme was developed by an independent editorial board, funded by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review for medical and scientific accuracy.

This series of podcasts are intended for healthcare professionals only.

The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.